Join
Live feed
·
INSIDERFilingvia Quantisnow
Amicus Therapeutics Inc. logo

President and CEO Campbell Bradley L sold $322,839 worth of shares (22,500 units at $14.35), decreasing direct ownership by 2% to 998,680 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FOLD· Amicus Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FOLD (Amicus Therapeutics Inc.) and more on Quantisnow.